Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | May 01, 2024 08:06am

Gainers

  • Akanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million.
  • NanoVibronix (NASDAQ:NAOV) shares moved upwards by 25.17% to $0.92. The market value of their outstanding shares is at $2.5 million.
  • Predictive Oncology (NASDAQ:POAI) shares increased by 23.4% to $1.74. The market value of their outstanding shares is at $7.0 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 19.0% to $0.99. The company's market cap stands at $1.7 million.
  • Emergent BioSolutions (NYSE:EBS) stock moved upwards by 18.08% to $2.22. The company's market cap stands at $116.3 million. As per the press release, Q1 earnings came out today.
  • IGC Pharma (AMEX:IGC) stock moved upwards by 17.15% to $0.64. The market value of their outstanding shares is at $42.4 million.

Losers

  • CVRx (NASDAQ:CVRX) stock fell 20.5% to $12.33 during Wednesday's pre-market session. The company's market cap stands at $266.2 million. As per the press release, Q1 earnings came out yesterday.
  • NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 18.22% to $2.11. The company's market cap stands at $22.1 million.
  • BiomX (AMEX:PHGE) shares decreased by 14.41% to $0.41. The market value of their outstanding shares is at $22.6 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock decreased by 11.8% to $1.87. The company's market cap stands at $2.4 million.
  • CVS Health (NYSE:CVS) stock decreased by 11.67% to $59.81. The market value of their outstanding shares is at $75.3 billion. As per the news, the Q1 earnings report came out today.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) stock decreased by 8.79% to $1.87. The market value of their outstanding shares is at $72.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKAN BRNS CVRX CVS CYCC EBS IGC LSDI NAOV NRXP PHGE POAI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist